Join Growin Stock Community!

博士旺3555.TW Overview

TW StockSemiconductor
(No presentation for 3555)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

博士旺(3555)Overall Performance

博士旺(3555)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

博士旺(3555) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

博士旺(3555)Key Information

博士旺(3555)Profile

iROC Co., Ltd. engages in the research and development, and sale of natural products in Japan. The company offers drinking water under the VACHI; skin care products under the QINGSKIN; and chicken essence under the DDDrops brand names, as well as DEDrops ginseng tonic drinks. It serves customers through online shops and distributors. The company was formerly known as Skymedi Corporation. The company was founded in 2003 and is based in New Taipei City, Taiwan.

博士旺(3555)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
10.58%
Net Margin
15.67%
Revenue Growth (YoY)
334.57%
Profit Growth (YoY)
67.25%
3-Year Revenue Growth
162.80%
3-Year Profit Growth
89.64%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
10.58%
Net Margin
15.67%
Revenue Growth (YoY)
334.57%
Profit Growth (YoY)
67.25%
3-Year Revenue Growth
162.80%
3-Year Profit Growth
89.64%
default symbol

3555

博士旺

121.00D

-5.37%

(-0.05)

  • When is 3555's latest earnings report released?

    The most recent financial report for 博士旺 (3555) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3555's short-term business performance and financial health. For the latest updates on 3555's earnings releases, visit this page regularly.

  • Where does 3555 fall in the P/E River chart?

    According to historical valuation range analysis, 博士旺 (3555)'s current price-to-earnings (P/E) ratio is 93.66, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 3555?

    According to the latest financial report, 博士旺 (3555) reported an Operating Profit of 4.69M with an Operating Margin of 4.44% this period, representing a growth of 227.2% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 3555's revenue growth?

    In the latest financial report, 博士旺 (3555) announced revenue of 105.56M, with a Year-Over-Year growth rate of 380.83%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 3555 have?

    At the end of the period, 博士旺 (3555) held Total Cash and Cash Equivalents of 135.1M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3555 go with three margins increasing?

    In the latest report, 博士旺 (3555) achieved the “three margins increasing” benchmark, with a gross margin of 18.45%%, operating margin of 4.44%%, and net margin of 59.13%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3555's profit trajectory and future growth potential.

  • Is 3555's EPS continuing to grow?

    According to the past four quarterly reports, 博士旺 (3555)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.83. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 3555?

    博士旺 (3555)'s Free Cash Flow (FCF) for the period is -14.53M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 349.39% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.